Tigress Financial started coverage on shares of USANA Health Sciences (NYSE:USNA) in a report issued on Tuesday, April 16th, AnalystRatings.com reports. The firm issued a buy rating on the stock.
Shares of USNA traded down $3.52 during mid-day trading on Tuesday, reaching $81.52. The company had a trading volume of 346,300 shares, compared to its average volume of 201,621. USANA Health Sciences has a 1-year low of $75.27 and a 1-year high of $137.95. The company has a market cap of $1.99 billion, a P/E ratio of 15.78 and a beta of 0.30.
USANA Health Sciences (NYSE:USNA) last posted its earnings results on Tuesday, April 30th. The company reported $1.01 EPS for the quarter, topping the consensus estimate of $0.99 by $0.02. USANA Health Sciences had a net margin of 10.38% and a return on equity of 29.03%. The business had revenue of $272.90 million for the quarter, compared to the consensus estimate of $272.20 million. During the same period last year, the company earned $1.19 EPS. The firm’s revenue was down 6.5% compared to the same quarter last year. On average, equities analysts predict that USANA Health Sciences will post 5.18 earnings per share for the current fiscal year.
Several large investors have recently added to or reduced their stakes in USNA. Campbell & CO Investment Adviser LLC bought a new stake in USANA Health Sciences during the 1st quarter valued at $211,000. Ontario Teachers Pension Plan Board bought a new stake in USANA Health Sciences during the 1st quarter valued at $271,000. Federated Investors Inc. PA increased its stake in USANA Health Sciences by 16.1% during the 1st quarter. Federated Investors Inc. PA now owns 114,283 shares of the company’s stock valued at $9,585,000 after purchasing an additional 15,881 shares in the last quarter. NumerixS Investment Technologies Inc increased its stake in USANA Health Sciences by 3,166.7% during the 1st quarter. NumerixS Investment Technologies Inc now owns 9,800 shares of the company’s stock valued at $816,000 after purchasing an additional 9,500 shares in the last quarter. Finally, Swiss National Bank increased its stake in USANA Health Sciences by 1.9% during the 1st quarter. Swiss National Bank now owns 21,800 shares of the company’s stock valued at $1,828,000 after purchasing an additional 400 shares in the last quarter. Institutional investors own 53.31% of the company’s stock.
USANA Health Sciences Company Profile
USANA Health Sciences, Inc develops, manufactures, and sells science-based nutritional and personal care products primarily to reduce the risk of chronic degenerative disease. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers comprising targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and foods that include low-glycemic meal replacement shakes, snack bars, and other related products, which provide macro-nutrition.
See Also: What is Cost of Debt?
Receive News & Ratings for USANA Health Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for USANA Health Sciences and related companies with MarketBeat.com's FREE daily email newsletter.